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dyskeratosis congenita
Shuang Li
1,2,3, Jingqi Duan
2,3, Dandan Li
2,
Shoucai Ma
2 and Keqiong Ye
2,*
1Department of Biochemistry and Molecular Biology, College of Life
Sciences, Beijing Normal University, Beijing, China and
2National
Institute of Biological Sciences, Beijing, China
Shq1 is a conserved protein required for the biogenesis of
eukaryotic H/ACA ribonucleoproteins (RNPs), including
human telomerase. We report the structure of the Shq1-
speciﬁc domain alone and in complex with H/ACA RNP
proteins Cbf5, Nop10 and Gar1. The Shq1-speciﬁc domain
adopts a novel helical fold and primarily contacts the PUA
domain and the otherwise disordered C-terminal exten-
sion (CTE) of Cbf5. The structure shows that dyskeratosis
congenita mutations found in the CTE of human Cbf5
likely interfere with Shq1 binding. However, most muta-
tions in the PUA domain are not located at the Shq1-
binding surface and also have little effect on the yeast
Cbf5–Shq1 interaction. Shq1 binds Cbf5 independently of
the H/ACA RNP proteins Nop10, Gar1 and Nhp2 and the
assembly factor Naf1, but shares an overlapping binding
surface with H/ACA RNA. Shq1 point mutations that
disrupt Cbf5 interaction suppress yeast growth particu-
larly at elevated temperatures. Our results suggest that
Shq1 functions as an assembly chaperone that protects the
Cbf5 protein complexes from non-speciﬁc RNA binding
and aggregation before assembly of H/ACA RNA.
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Introduction
Box H/ACA RNAs constitute a large family of non-coding
RNAs conserved in archaea and eukaryotes (Meier, 2005;
Matera et al, 2007; Kiss et al, 2010). Each distinct H/ACA RNA
assembles with a common set of four proteins, Cbf5 (NAP57
in rodents and dyskerin in humans), Nop10, Nhp2 (L7Ae in
archaea) and Gar1 to form an H/ACA ribonucleoprotein
(RNP) particle. The function of most H/ACA RNPs is to
convert uridine into pseudouridine at numerous speciﬁc
sites within ribosomal RNAs (rRNAs) and spliceosomal
small nuclear RNAs (snRNAs), and the substrate speciﬁcity
is determined by the H/ACA RNA. However, the snR30/U17
H/ACA RNP and human telomerase are involved in precursor
rRNA processing and telomere formation, respectively.
Human telomerase contains the reverse transcriptase
hTERT, the telomerase RNA hTR as well as the four H/ACA
proteins that associate with an H/ACA domain in hTR, which
is required for telomerase in-vivo assembly, localization and
activity (Mitchell et al, 1999).
Dyskeratosis congenita (DC) is a rare genetic disease
characterized by a classic triad of nail dystrophy, abnormal
skin pigmentation and oral leukoplakia as well as by bone
marrow failure, pulmonary ﬁbrosis, cancer and other com-
plications (Walne and Dokal, 2009; Bessler et al, 2010). DC is
considered as a telomere deﬁciency disorder, because DC
patients show very short telomere in highly proliferating
tissues and the causal mutations found so far are all located
in genes that control telomere homeostasis, including the
telomerase components dyskerin, hTR, hTERT, Nop10 and
Nhp2, the telomere protecting protein TIN2 and the telomer-
ase trafﬁcking factor TCAB1 (Zhong et al, 2011). Mutations in
dyskerin cause the most frequent X-linked form of DC (Heiss
et al, 1998). DC mutations have been shown to interfere with
telomerase stability, assembly, activity and localization
(Mochizuki et al, 2004; Trahan and Dragon, 2009; Robart
and Collins, 2010; Trahan et al, 2010; Batista et al, 2011).
In eukaryotes, mature H/ACA RNPs that modify rRNAs are
localized in the nucleolus, the place of ribosome assembly,
and those that modify snRNAs are found in the Cajal bodies
(Darzacq et al, 2002). According to the different localization,
H/ACA RNA/RNPs are classiﬁed as small nucleolar (sno) and
small Cajal body-speciﬁc (sca) RNA/RNPs. H/ACA scaRNAs,
including hTR, are directed to the Cajal bodies by a CAB motif
in the apical loop (Richard et al, 2003; Jady et al, 2004).
An H/ACA RNA and the four core proteins can assemble
spontaneously in vitro into an active enzyme in both archaeal
and eukaryotic systems (Baker et al, 2005; Charpentier et al,
2005; Li et al, 2011). However, assembly of eukaryotic H/ACA
RNPs is highly complicated in vivo and requires several
general as well as H/ACA-speciﬁc assembly factors (Kiss
et al, 2010). The chaperone heat-shock protein 90 (Hsp90)
and its associated proteins have been shown to be involved in
assembly of H/ACA, C/D and other RNPs that all contain a
L7Ae-related protein (Boulon et al, 2008; Venteicher et al,
2008; Zhao et al, 2008). Two conserved proteins, Naf1 and
Shq1, are speciﬁcally required for H/ACA RNP formation in
yeast Saccharomyces cerevisiae (Dez et al, 2002; Fatica et al,
2002; Yang et al, 2002) and in mammalian cells (Darzacq
et al, 2006; Hoareau-Aveilla et al, 2006; Grozdanov et al,
2009b). Naf1 and Shq1 are localized in the nucleoplasm and
excluded from nucleoli and Cajal bodies, where mature
H/ACA RNPs reside (Dez et al,2 0 0 2 ;F a t i c aet al, 2002; Yang
et al, 2002; Darzacq et al, 2006; Grozdanov et al, 2009b). Received: 1 August 2011; accepted: 7 November 2011
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1H/ACA RNP proteins Cbf5, Nhp2 and Nop10 and assembly
factor Naf1 are recruited to the site of H/ACA RNA genes,
suggesting that the four proteins assemble with the nascent
H/ACA RNAs into precursor RNPs (pre-RNPs) (Ballarino
et al, 2005; Yang et al, 2005; Darzacq et al, 2006). Naf1
shares a homologous core domain with Gar1 (Leulliot et al,
2007) and associates with Cbf5 (Darzacq et al, 2006). We
recently showed that the H/ACA pre-RNP assembled with
Naf1 possesses basic pseudouridylation activity but is incap-
able of substrate turnover and replacement of Naf1 by Gar1
yields a fully active enzyme (Li et al, 2011).
Shq1 appears to be an early assembly factor that, unlike
Naf1, is not associated with the H/ACA RNA genes in yeast
and mammalian cells (Yang et al, 2005; Grozdanov et al,
2009b). Shq1 is composed of an N-terminal CS (CHORD-
containing proteins and Sgt1) domain and a C-terminal Shq1-
speciﬁc domain (SSD). The structure of the CS domain has
been determined by crystallography and NMR (Godin et al,
2009; Singh et al, 2009). The CS domain adopts a b-sandwich
structure similar to that of Hsp20 superfamily proteins, which
are co-chaperones of Hsp90. However, no interaction has
been found between the CS domain of Shq1 and yeast Hsp90
(Godin et al, 2009; Singh et al, 2009). The SSD interacts with
the PUA domain of Cbf5 and some of DC mutations in the
PUA domain were shown to modulate Shq1 binding
(Grozdanov et al, 2009a). The molecular function of Shq1
remains unclear.
In this study, we analyse the Shq1–Cbf5 interaction by
using X-ray crystallography, biochemical approaches, muta-
genesis and yeast experiments. Our results reveal the struc-
tural details of Shq1–Cbf5 recognition and provide novel
insights into the function of Shq1 in H/ACA RNP biogenesis
and the effect of DC mutations in dyskerin.
Results
Shq1 binds Cbf5 independently of other Cbf5-
interacting proteins
The isolated Cbf5 protein has poor solubility, impeding
analysis of its interaction with Shq1. By co-expression and
co-puriﬁcation of yeast Cbf5 with Nop10 or with both Nop10
and Gar1, we recently obtained soluble Cbf5 complexes of
various compositions that are functional in RNP assembly
and pseudouridylation (Li et al, 2011). The structure of the
yeast Cbf5–Nop10–Gar1 (CNG) ternary complex has also
been determined (Li et al, 2011). These progresses allowed
us to examine the interaction of Shq1 with Cbf5 complexes in
detail (Figure 1A). Yeast Cbf5 possesses a core domain
(residues 1–394) and a C-terminal KKE/D repeat tail and
yeast Gar1 has a core domain ﬂanked by two genetically
dispensable Gly/Arg-rich (GAR) domains (Girard et al, 1994;
Pogacic et al, 2000). Unless otherwise indicated, we used the
core domain of Cbf5 and Gar1 and the Gar1-like core domain
of Naf1 (residues 107–280) for biochemical and structural
studies (Leulliot et al, 2007).
We incubated puriﬁed full-length Shq1 with the Cbf5
complexes and used Ni beads to pull down His-tagged
Cbf5. The Cbf5–Nop10 complex retained a stoichiometric
amount of Shq1, whereas the Ni beads alone retained only
a background amount of Shq1, indicating a speciﬁc interac-
tion between Shq1 and the Cbf5–Nop10 complex. This result
is somewhat surprising as a previous study with in-vitro
translated rat proteins showed that Shq1 only binds NAP57
(rat Cbf5) alone but not NAP57 in complex with Nop10, Nhp2
and Naf1 (Grozdanov et al, 2009b). As expression of Cbf5
alone produced protein aggregates that cannot be puriﬁed,
we were not able to examine whether Cbf5 has a higher
binding afﬁnity for Shq1 than the Cbf5–Nop10 complex.
Nevertheless, our results indicate that Cbf5 can bind simul-
taneously to Shq1 and Nop10.
We further examined whether the other H/ACA RNP
proteins Nhp2 and Gar1 and the assembly factor Naf1 affect
the Shq1 interaction. The incorporation of these proteins in
various combinations into the Cbf5–Nop10 complex also had
no effect on Shq1 retention (Figure 1A). Moreover, the
compositions of the retained Cbf5 complexes were not chan-
ged in all cases before and after Shq1 binding, indicating that
Shq1 does not disrupt the pre-assembled Cbf5 complex
structures. Shq1 was similarly bound by the Cbf5 complexes
assembled with full-length Cbf5 and full-length Gar1 (par-
tially degraded), indicating that the C-terminal KEE/D tail of
Cbf5 and the GAR domains of Gar1 do not interfere with the
Shq1 association (Figure 1B).
Isothermal titration calorimetry (ITC) measurements
showed that Shq1 binds tightly to Cbf5–Nop10 with an
apparent dissociation constant (Kd)o f4 5 ±27nM
(Figure 1C). The association of Gar1 and Nhp2 did not affect
the binding afﬁnity within experimental error. We can
conclude that Shq1 contacts Cbf5 independently of the
other Cbf5-interacting proteins in vitro.
Crystal structure of the Shq1-speciﬁc domain
The C-terminal SSD of Shq1 has been shown to interact with
Cbf5 (Godin et al, 2009; Grozdanov et al, 2009b). We con-
ﬁrmed this interaction using our recombinant yeast proteins
by pull-down assay and ITC (unpublished observation). To
further understand the function of the SSD, we determined its
crystal structure by selenium phasing. The structure was
reﬁned to 1.6A ˚ resolution with an Rwork/Rfree of 0.168/
0.198 (Table 1; Supplementary Figure S1). The structure
shows that the SSD encompasses residues 164 to close to
the C-terminus of Shq1 and adopts a unique globular fold
with dimensions of B73 66 41 A ˚ (Figure 2A–D). The
structure is mostly helical and consists of 17 a-helices
(a1–a17) and 2 short b-strands (b1–b2). Helix a8 is located
at the centre of the structure and is wrapped by two clockwise
circles of a-helices. Helices a1–a7 comprise the outer ring,
whereas helices a9–a16 form the inner ring. Strands b1 and
b2, which form a b-hairpin, and helix a17 form a V-shaped
structure packed at the outside. Two loops connecting helices
a10 and a11 (residues 346–362) and strands b1 and b2
(residues 472–482) were not visible in the crystal and are
likely disordered.
The fold of the SSD is unprecedented. Structural homo-
logues (Z-score o3.6) identiﬁed by the Dali server show
limited similarity only to helices a8–a12 of the SSD structure
(Holm and Sander, 1993). This region adopts a 4-helix
bundle, a common motif embedded in many proteins with
diverse functions, including cyclin and retinoblastoma tu-
mour suppressor. The implication of this limited structure
homology is not clear. The structure also contains an unusual
buried charge cluster that is composed of highly conserved
arginine and acidic residues and mediates the packing of
helices a2 and a11 (Supplementary Figure S2; Figure 2D).
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complex with Cbf5, Nop10 and Gar1
To reveal the molecular detail of the Shq1–Cbf5 interaction,
we determined the crystal structure of the SSD in complex
with Cbf5, Nop10 and Gar1 at 3.06A ˚ resolution. The structure
was solved by molecular replacement and reﬁned to an
Rwork/Rfree of 0.218/0.275 (Table 1).
The quaternary complex structure shows that Shq1 exclu-
sively contacts Cbf5 at the PUA domain, the C-terminal
extension (CTE) and a small part of the catalytic domain
(Figures 3A and 4). The Shq1–Cbf5 complex buries 1803A ˚ 2
of solvent accessible area in Cbf5, with 612A ˚ 2 contributed
by the PUA domain, 1082A ˚ 2 by the CTE and 109A ˚ 2 by the
catalytic domain.
In the Shq1 complex structure, the Shq1-binding interface
on Cbf5 is well separated from that of Nop10 and Gar1.
The assembly factor Naf1 most likely binds Cbf5 at
the same site as Gar1, and Nhp2 probably binds Nop10
(Li and Ye, 2006; Li et al, 2011). These structural observations
and predictions indicate that Shq1 would not interfere
with the interaction of Cbf5 with these proteins, in agreement
with our biochemical results (Figure 1). The PUA domain is
also the anchoring site for the lower stem and the ACA
motif of H/ACA RNA (Li and Ye, 2006). Alignment of
the Pyrococcus furiosus (Pf) H/ACA RNP structure
shows that Shq1 and the H/ACA RNA share a largely over-
lapping interface on the PUA domain, indicating that they
interact with Cbf5 in a mutually exclusive manner
(Figure 3B).
Structural change upon Shq1–Cbf5 association
The structures of SSD alone and in the Cbf5 complex can be
superimposed over the entire structure with an r.m.s.d. of
0.303A ˚ over 298 Ca pairs (Supplementary Figure S3). This
indicates that Shq1 provides a rather rigid interface for Cbf5
interaction. One exception is the C-terminal b-hairpin of
Shq1, the apical portion of which is disordered in the free
state but is largely structured upon Cbf5 binding.
Compared with the CNG structure (Li et al, 2011), the Cbf5
structure undergoes several changes upon Shq1 association.
Most dramatically, the Cbf5 CTE, which was ﬂexible and
degraded in the CNG structure, becomes largely structured in
the Shq1 complex. The PUA domain rotates 81 relative to the
catalytic domain owing to the plastic connection between
them, as previously seen in the archaeal Cbf5 structure (Duan
et al, 2009). At the centre of the Shq1-binding interface, local
conformational changes were observed in the loop connect-
ing helix a8 and strand b30. However, this region in the CNG
structure is involved in crystal packing and its conformation
in the Shq1 complex better resembles that in archaeal Cbf5.
The N-terminal residues 1–17 of Cbf5 were not visible in the
Shq1 complex structure, probably because of degradation.
Loop L1 formed by residues 5–11 was only occasionally
observed with high temperature factors in the CNG complex
structure (Li et al, 2011).
Shq1–Cbf5 interaction
Shq1 contacts Cbf5 mainly through charge complementarity
and hydrophobic contacts. At the centre of the interface, the
Figure 1 Interaction between Shq1 and the Cbf5 complexes. (A) Shq1 binds Cbf5 independently of other proteins. The Cbf5 complexes are
denoted by concatenated abbreviations of the constituent proteins: C for Cbf5 (1–394), CD354 for Cbf5 (1–354), N for Nop10, G for Gar1 (32–
124), P for Nhp2 and F for Naf1 (107–280). The Cbf5 complexes were incubated with Shq1 and Ni beads in 50mM sodium phosphate (pH 7.6)
and 0.4M KCl for 2h at 41C. Among these proteins, only Cbf5 contained a His tag. Half of the bound protein was analysed on Coomassie blue-
stained SDS–PAGE gels. Lane 1: 100% of the Shq1 input. Lane 2: non-speciﬁcally retained Shq1. The migration position and amino-acid
boundaries of each protein are labelled. The asterisks indicate unidentiﬁed proteins from the Shq1 sample that bound strongly to Ni beads.
(B) Shq1 pull-down assay with Cbf5 complexes containing full-length Cbf5 (C*), Cbf5 (1–354) or full-length Gar1 (G*). Full-length Gar1 was
partially degraded. (C) ITC analysis of Shq1–Cbf5 interaction. Shq1 was titrated into the indicated Cbf5 complexes. The upper panels show the
heat change upon injection, and the lower panels show the integrated heat curves that were ﬁt using a one-set-of-sites model. The apparent
dissociation constants are indicated.
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of Shq1 binds helix a8, strands b30 and b17, and the loop
C-terminal to b17 of Cbf5 (Figure 4C). Speciﬁcally, the planar
guanidinium group of Cbf5 Arg343 stacks over the indole
ring of Shq1 Trp326 and forms a salt bridge with the side
chain of Shq1 Glu323. The aromatic ring of Cbf5 Try281 packs
against the hydrophobic side chain of Shq1 Leu381 and
makes a hydrogen bond with the side chain amino of mostly
buried Shq1 Arg383, which is also within the electrostatic
contact distance of Cbf5 Asp344. These Cbf5-interacting
residues (Trp326, Glu323, Leu381 and Arg383) are highly
conserved in Shq1 and form a small surface patch, in contrast
to a general lack of conservation in the other surface areas of
the Shq1 structure (Figures 2D and 4D). Consistent with their
structural role in Cbf5 binding and the high degree of con-
servation, the replacement of the hydrophobic Trp326 residue
with a charged aspartate and the substitution of Arg383 with
a negatively charged glutamate signiﬁcantly reduced the
Shq1–Cbf5 interaction in ITC experiments (Figure 4F).
These mutant proteins showed the same elution proﬁle in
sizing columns as wild-type Shq1 and some residual binding
to Cbf5 in ITC, indicating that they remain correctly folded.
At the periphery of the interface, the loop C-terminal to
helix a1 and residue Asp421 in loop a13–a14 of Shq1 contact
a small area of the Cbf5 catalytic domain, which is around
helix a2 and adjacent to the PUA domain (Figure 4C). Shq1
Asp421 makes an electrostatic contact with Cbf5 Lys114.
Although the interacting pair is conserved in the respective
proteins, mutation of Asp421 to lysine did not apparently
affect the binding afﬁnity (Figure 4F), suggesting that this
interaction makes a minor energetic contribution. At the
other side of the interface, helix a4 of Shq1, which however
is not conserved in the human protein, contacts helix a8 and
loop b30–b20 of Cbf5 (Figure 4A and C).
The CTE was not observed in the CNG structure because of
ﬂexibility and degradation (Li et al, 2011). In the Shq1
complex structure, the CTE to residue 378 forms an extended
structure over the surface of Shq1 (Figure 4D and E). The CTE
contains a-helix a30 (residues 355–364) ﬂanked by two loops.
The loop connecting helix a30 to the PUA domain contacts
helices a3 and a17 of Shq1 mainly via the hydrophobic
residues Trp350 and Leu352 (Figure 4D). The a30 helix of
Cbf5 packs perpendicularly against the inner walls of the V-
shaped structure formed by the C-terminal b1–b2 hairpin and
helix a17 of Shq1, and the C-terminal loop of Cbf5 hooks at
the edge of the Shq1 structure. In this region, the Shq1–Cbf5
interaction is mediated by numerous electrostatic interactions
mainly between basic residues in Cbf5 and acidic residues in
Shq1 (Figure 4A and D). In addition, Cbf5 Met362, Val374
and Leu368 and Shq1 Leu494 form a small hydrophobic core
at the molecular interface (Figure 4D). Consistent with the
structural observation, truncation of the C-terminal region of
Cbf5 after residue 354 (Cbf5D354), which removes helix a30
and the following loop, reduces the Shq1-binding afﬁnity by
B4-fold (Figure 1B and C). The structure shows that the
conserved negatively charged residue Glu219 of Shq1 caps
the positively charged N-terminus of Cbf5 helix a30 and likely
neutralizes the helix dipole (Figure 4D). However, mutation
E219K has little effect on Cbf5 binding (Figure 4F).
Shq1 mutants in yeast
To investigate the functional importance of the Shq1–Cbf5
interaction, we made a Shq1 knockout haploid strain and
complemented it with Shq1 mutants (Figure 5A). Deletion of
Table 1 Data collection and reﬁnement statistics
Crystal form Native SSD Se SSD SSD–Cbf5–Nop10–Gar1
Data collection
Space group P1 P1 P43212
Cell dimensions
a, b, c (A ˚) 39.1, 50.1, 54.0 39.2, 50.1, 54.0 101.0, 101.0, 272.3
a, b, g (deg) 102.2, 93.8, 98.0 102.3, 94.0, 97.5 90, 90, 90
Wavelength (A ˚) 0.9792 0.9793 0.9789
X-ray source SSRF BL17U1 SSRF BL17U1 SSRF BL17U1
Resolution range (A ˚)
a 50–1.6 (1.63–1.60) 50–2.1 (2.14–2.1) 50–3.06 (3.11–3.06)
Unique reﬂections 50317 20594 27487
Redundancy 3.9 (4.0) 3.6 (3.6) 14.1 (14.7)
I/s 42.5 (14.1) 25.1 (10.2) 58.4 (5.6)
Completeness (%) 96.8 (95.3) 89.4 (96.7) 99.9 (100)
Rmerge
b 0.057 (0.132) 0.091 (0.173) 0.067 (0.684)
Structure reﬁnement
Resolution range (A ˚) 20–1.6 (1.64–1.6) 20–3.06 (3.14–3.06)
No. of reﬂections 47740 25934
No. of atoms 2929 6627
Mean B factor (A ˚ 2) 13.6 100.6
Rwork
c 0.168 (0.173) 0.218 (0.279)
Rfree
d 0.198 (0.201) 0.275 (0.332)
R.m.s.d. bond length (A ˚) 0.010 0.009
R.m.s.d. bond angles (deg) 1.212 1.210
RAMPAGE statistics
e
Favoured (%) 98.4 92.1
Allowed (%) 1.3 7.0
Outlier (%) 0.3 0.9
aThe values for the data in the highest resolution shell are shown in parentheses.
bRmerge¼S|Ii Im|/SIi, where Ii is the intensity of the measured reﬂection and Im is the mean intensity of all symmetry related reﬂections.
cRwork¼Sh|Fo Fc|/ShFo, where Fo and Fc are the observed and calculated structure factor amplitudes of reﬂection h.
dRfree is the same as Rwork, but calculated on 5% reﬂections not used in reﬁnement.
eAnalysed by RAMPAGE including general residues, glycine, proline and pre-proline.
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with the previous results (Singh et al, 2009). Moreover,
removal of the entire SSD was lethal, indicating that the
SSD is also essential for yeast viability. Among the point
mutations that impair the Shq1–Cbf5 interaction in ITC
experiments, R383E reduced cell growth at 301C, but
W326D showed nearly normal growth at 301C. We further
examined how temperature inﬂuences the growth phenotype
of these mutations. Interestingly, the growth of R383E and
W326D mutants was severely inhibited at 371C, but were
nearly normal at 201C (Figure 5B). The temperature-depen-
dent phenotype was not due to the reduced protein level of
Shq1 mutants at high temperatures (Figure 5C). These results
indicate that disruption of the Shq1–Cbf5 interaction is detri-
mental, particularly at high growth temperatures.
DC mutations and Shq1 binding
A majority of X-linked DC mutations are clustered on the
N- and C-terminal regions of Cbf5, part of which constitute
the PUA domain (Marrone et al, 2005). Compared with their
archaeal counterparts, eukaryotic Cbf5 proteins contain the
N-terminal extension (NTE) and CTE (Figure 6A). These
two extensions are highly conserved in eukaryotes and
harbour many DC mutations. The crystal structure of the
CNG complex showed that the NTE folds into a new structur-
al layer covering on the PUA domain, whereas the CTE is
disordered (Li et al, 2011). The Shq1 complex structure now
reveals a novel function for the CTE in mediating Shq1
association.
The Shq1 complex structure shows that yeast residues
Pro354, Ala356, Leu368, Gly372, Thr378 and Pro379 in the
CTE and K284 in the PUA domain, which correspond to
DC mutation sites, are located at the Shq1-binding interface
(Figure 6B). DC mutations at these sites may affect Shq1
binding and hence H/ACA RNP and telomerase biogenesis.
The truncation mutant Cbf5D354, which lacks a large
portion of the CTE, could be regarded as an extreme model
for DC mutations in the CTE. As shown above (Figure 1B),
Cbf5D354 shows a 4-fold weaker Shq1-binding afﬁnity than
Cbf5 with a complete CTE. A single site DC mutation in this
region should display a milder effect on Shq1 binding than
Cbf5D354.
However, most of DC mutation sites in the PUA domain are
not located at the binding surface for Shq1 or RNA
(Figure 6B). Nevertheless, the effect on Shq1 binding of
mutations at these sites may be indirect. To experimentally
test this notion, we used the yeast Cbf5 protein to assess
whether nine DC mutations in the PUA domain affect Shq1
binding (Figure 6C). Seven sites were substituted with the
exact amino acid found in DC patients (I8T, K9E, E11K, T19M,
R35T, S36A and L291F), while the other two sites were
replaced with amino acid with more different physicochem-
Figure 2 Crystal structure of the Shq1-speciﬁc domain (SSD). (A) Domain organization of Shq1. The CS domain and SSD are labelled.
(B) Ribbon representation of the SSD structure in cross-eye stereo-view. The secondary structural elements are indicated. The central helix a8i s
green, the outer helical circle is blue, the inner helical circle is orange and the C-terminal structural elements are red. The N- and C-termini are
marked by ‘N’ and ‘C’. Dots are used to represent the disordered loops. (C) Topology diagram of the SSD structure. (D) Sequence alignment of
the SSD. Ninety Shq1 proteins were aligned, but only the S. cerevisiae (Sc) and H. sapiens (Hs) sequences are shown. Residues that are
conserved in at least 95, 80 and 60% of the 90 Shq1 proteins are shaded by black, grey and light grey, respectively. The secondary structure
elements observed in the free SSD structure are indicated above the alignment. Residues with solvent accessible surface buried by at least 30
and 10A ˚ 2 owing to Cbf5 association are marked by red solid and open circles, respectively.
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deletion mutant DN15 that removed the N-terminal 15
residues including 7 DC mutation sites.
These Cbf5 DC mutants were co-puriﬁed with Nop10, or
with Nop10 and Gar1 for a better solubility, and assessed
for Shq1 binding using the Ni-bead pull-down assay
(Figure 6C). To assess the sensitivity of the pull-down
assay, we included Cbf5D354 as a negative control, whose
Shq1-binding afﬁnity has been quantiﬁed with ITC. The
results show that Cbf5D354 retained much less Shq1 com-
pared with Cbf5 with an intact CTE (lane 4), indicating that
the pull-down assay is sensitive enough to detect a 4-fold
reduction in binding afﬁnity. All of the DC mutants and DN15
retained stoichiometric amounts of Shq1 similarly to wild-
type Cbf5. These results indicate that these DC mutations in
the PUA domain of yeast Cbf5 do not appreciably affect Shq1
binding.
Discussion
Shq1 is an H/ACA RNP assembly chaperone
As an assembly factor, Shq1 is present neither in mature
H/ACA RNPs nor in H/ACA pre-RNPs assembled at H/ACA
RNA genes. The mechanism by which Shq1 is excluded from
H/ACA RNPs has been ascribed to the presence of other
Cbf5-associated proteins (Grozdanov et al, 2009b). We have
shown, by biochemical and structural analysis, that the
H/ACA RNP proteins Nop10, Nhp2 and Gar1 and the assem-
bly factor Naf1 do not interfere with the Shq1–Cbf5 interac-
tion in vitro. Rather, H/ACA RNAs could dislodge Shq1 from
Cbf5, as they share an overlapping binding site on the PUA
domain. Our data also suggest that Shq1 transfers the pre-
assembled Cbf5 protein complexes to nascent H/ACA RNAs.
The discrepancy between our results and the previous
studies (Grozdanov et al, 2009b) may be because the yeast
proteins we used have species-speciﬁc differences compared
with their rat counterparts, which were used previously.
However, this possibility seems unlikely as the sequences of
H/ACA RNP proteins are highly conserved in eukaryotes.
Alternatively, the previous studies were performed in rabbit
reticulocyte lysates or in mammalian cells and the endogen-
ous H/ACA RNAs present in these systems might interfere
with the Shq1–Cbf5 interaction.
The PUA domain of Cbf5 is a major RNA binding domain
recognizing the lower stem and ACA motif of H/ACA RNAs
(Li and Ye, 2006). The Shq1 blockage of the PUA domain
would prevent illicit binding of non-speciﬁc RNAs before
Cbf5 assembles with H/ACA RNAs. In this regard, Shq1 fulﬁls
the role as an assembly chaperone. Assembly chaperones
associate with assembly intermediates of many macromole-
cular complexes to pre-organize individual subunits and
prevent pre-mature interactions or dead-end products
(Chari and Fischer, 2010). Recently, two assembly chaperones
involved in snRNP biogenesis were structurally illustrated.
The Gemin2 protein of the SMN complex was shown to wrap
around a Sm pentamer complex and block RNA binding
(Zhang et al, 2011). Aar2, a U5 snRNP assembly factor, was
shown to bind Prp8 and prevent the association of Brr2,
which is present in mature U5 snRNP (Weber et al, 2011).
Assembly chaperones also trap the complexes in inter-
mediate states that need to be disassembled before the next
step of assembly (Chari and Fischer, 2010). The competitive
binding of H/ACA RNA might provide a mechanism for Shq1
displacement from H/ACA RNPs. We analysed the Cbf5
binding competition between H/ACA RNA and Shq1, but
obtained different results for two tested RNAs snR5 and
snR36Dins, which is a derivative of snR36 lacking an inser-
tion in the 50 hairpin (unpublished observation). SnR36Dins,
but not snR5, can displace Shq1 from the Cbf5–Nop10–Gar1–
Nhp2 complex. In the case of snR36Dins, Shq1 displacement
was reduced in the absence of Nhp2, suggesting that Nhp2,
which presumably binds the upper stem of H/ACA RNA,
enhances the competition ability of the H/ACA RNA. The two
RNAs appear to possess different binding afﬁnities to Cbf5
complexes. Moreover, direct RNA competition may not be
the sole driving force for the in-vivo displacement of Shq1
and other factors likely exist to help disassemble the Shq1
complex.
We show that the phenotype of two Shq1 point mutations
that impair Cbf5 interaction strongly depends on the growth
temperature. The suppression of yeast growth was pro-
nounced at 371C, but largely disappeared at 201C
(Figure 5). The Shq1–Cbf5 interaction may be stabilized at
low temperature, partially compensating the disruptive effect
of the mutations. Alternatively, Shq1 may protect Cbf5 from
misfolding and/or aggregation, which is expected to be more
Figure 3 Structure of the SSD–Cbf5–Nop10–Gar1 complex.
(A) Ribbon representation of the structure, shown in two orthogo-
nal views. Cbf5 is green, Nop10 is magenta, Gar1 is cyan and Shq1
is wheat. (B) Surface view of the Shq1 complex and the P. furiosus
H/ACA RNP structure. The two structures are aligned by the
catalytic domain of Cbf5. The RNA is yellow.
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general chaperone activity in vitro that suppresses thermally
induced aggregation of citrate synthase in a stoichiometric
manner (Godin et al, 2009). The CS domain of Shq1 is
structurally similar to Hsp20 proteins, which usually bind
to the Hsp90 chaperone and regulate its activity. However, no
interaction has been detected between Hsp90 and the CS
domain (Godin et al, 2009; Singh et al, 2009). Hsp90 has been
shown to be involved in H/ACA RNP biogenesis (Boulon
et al, 2008; Zhao et al, 2008). The exact role of Shq1 in
H/ACA RNP biogenesis and its connection to other chaper-
ones remain to be sorted out.
DC mutations and Shq1 interaction
Most DC mutants in dyskerin are clustered on the PUA
domain and the eukaryote-speciﬁc NTE and CTE. The pre-
vious archaeal Cbf5 structure cannot be used to model many
DC mutations in the extensions. The structures of yeast Cbf5
reveal the role of the NTE in building an enlarged eukaryotic
PUA domain and the CTE in binding Shq1, providing a new
framework for investigation of the effect of DC mutations.
We introduced a few DC mutations into the PUA domain of
yeast Cbf5 but did not detect an effect on the Cbf5–Shq1
interaction. The mutational effects on Shq1 binding might be
too subtle to be detected by our in-vitro method, but may
remain signiﬁcant in vivo. It is also possible that DC muta-
tions affect the protein stability in vivo and the PUA domain
is involved in additional unknown functions besides binding
H/ACA RNA and Shq1. A previous study showed that several
mutations at DC sites in the PUA domain modulate the
interaction between rat MBP-NAP57 and human SHQ1
(Grozdanov et al, 2009b). It should be noted that we mea-
sured the binding between yeast Shq1 and Cbf5 in 400mM
salt, while in such a concentration of salt the interaction
between rat MBP-NAP57 and human SHQ1 was largely
disrupted (Grozdanov et al, 2009a). The different properties
of the proteins used may lead to some difference in our and
the previous studies.
Figure 4 Interaction between Shq1 and Cbf5. (A) Electrostatic potential surface of the Shq1 domain in two opposite orientations. The surface
is coloured from red to blue for negatively to positively charged regions. (B) Conserved surface of the Shq1 domain in two opposite
orientations. Residues with at least 95 and 80% conservation as deﬁned in Figure 2D are coloured in red and pink, respectively. (C) Interactions
between Shq1 and the PUA domain of Cbf5. Interacting residues are shown as sticks with the oxygen atoms in red, the nitrogen atoms
in blue and the carbon atoms in green for Cbf5 and in wheat for Shq1. Dashed lines denote hydrogen bonds. Residues analysed by mutagenesis
are boxed. (D) Interactions between Shq1 and the C-terminal extension of Cbf5. (E) The 2fo fc electron density map counted at the 1s level is
shown for Cbf5. (F) ITC proﬁles of Shq1 and mutants with the Cbf5–Nop10 complex. The Kd values are indicated.
Shq1 structure and function
SL iet al
&2011 European Molecular Biology Organization The EMBO Journal 7Materials and methods
DNA constructs and protein puriﬁcation
The sequence encoding full-length Shq1 (residues 1–507) was
ampliﬁed by PCR from yeast genomic DNA and cloned into the ﬁrst
multiple cloning site of a modiﬁed pETDuet-1 plasmid (Novagen).
The gene encoding the SSD (residues 147–507) was ampliﬁed from
the full-length Shq1 gene and cloned similarly. The Shq1 proteins
were expressed as fusion proteins with an N-terminal 6-histidine
tag, thioredoxin (Trx) and a linker with a PreScission cleavage site.
Point mutants were generated by the QuikChange method
(Stratagene) and conﬁrmed by DNA sequencing.
Shq1 and the SSD were expressed in the E. coli Rosetta 2 (DE3)
strain (Novagen). The expression bacteria were cultured in LB
medium containing 50mgml
 1 ampicillin and 34mgml
 1 chloram-
phenicol at 371Ct oa nO D 600 of 1.0; 1mM IPTG was then added for
protein induction overnight at 181C. The cells harvested from 2L of
culture were resuspended in 100ml buffer A (50mM sodium
phosphate (pH 7.6) and 300mM NaCl), lysed with a high-pressure
cell disruptor and centrifuged to remove the cell debris. The
supernatant was applied to a 5-ml HisTrap column (GE Healthcare)
equilibrated in buffer A. The column was washed with 50ml buffer
A and with 50ml buffer A supplemented with 20mM imidazole.
The target protein was eluted with 500mM imidazole in buffer A
and supplemented with 2mM dithiothreitol. To remove the
N-terminal His-Trx tag, the protein was incubated with recombinant
PreScission protease overnight at 41C. The digested protein was
diluted by adding two volumes of buffer B (25mM HEPES-Na (pH
7.6)), loaded onto a 5-ml HisTrap Q column (GE Healthcare) pre-
equilibrated with buffer B and eluted with a 0–1M NaCl gradient.
Fractions containing the target protein were pooled, concentrated to
2ml and further puriﬁed with a Superdex S200 16/60 column
equilibrated in 10mM HEPES-K (pH 7.6) and 100mM NaCl. The
protein was concentrated to 40mgml
 1, divided into aliquots and
stored at  801C.
The SSD was labelled with selenomethionine in M9 medium
by blocking methionine biosynthesis (Van Duyne et al, 1993).
Se-labelled protein was puriﬁed by the same procedure as
unlabelled protein except that the lysis buffer was supplemented
with 10mM b-mercaptoethanol.
For puriﬁcation of the Shq1–Cbf5–Nop10–Gar1 complex, the
CNG complex was puriﬁed by HisTrap and heparin chromatography
as described (Li et al, 2011). The His tag of Gar1 was not cleaved.
The SSD was puriﬁed after Q chromatography as described above.
The CNG complex was mixed with the SSD in a 1:3molar ratio and
incubated on ice overnight. The quaternary complex was separated
from excessive free SSD on a Superdex S200 16/60 column.
Crystallization
The crystal of the SSD alone was grown using the hanging-drop
vapour-diffusion method by mixing 1mlo f4 0 m g m l
 1 Shq1 (147–
507) in 10mM HEPES-K (pH 7.5) and 100mM NaCl and 1mlo f
reservoir solution containing 0.1M tri-sodium citrate (pH 6.0), 0.2M
ammonium acetate, 20% w/v PEG 4000 and 9% isopropanol. Rod-
shaped crystals appeared in 2 days for the native protein at 201Ca n d
in 2 weeks for the Se-labelled protein at 41C. The crystals were
cryoprotected in 20% glycerol made in the reservoir solution and
ﬂash frozen in liquid nitrogen. The crystal of the Shq1–Cbf5–Nop10–
Gar1 complex (20mgml
 1 in 50mM Tris–Cl (pH 8.0), 500mM NaCl,
10% glycerol and 1mM DTT) was grown in 0.1M Bis-Tris (pH 6.5)
and 20% w/v polyethylene glycol monomethyl ether 5000 at 201C
and cryoprotected in 16% glycerol in the reservoir solution.
Data collection and structure determination
Diffraction data were collected at the Shanghai Synchrotron
Radiation Facility beamline BL17U1 and processed by HKL2000
(Otwinowski and Minor, 1997). The crystal of the SSD belongs to
space group P1 and contains one molecule per asymmetric unit.
The SSD structure was solved by the isomorphous replacement with
anomalous scattering method based on a 1.6-A ˚ native data set and a
2.1-A ˚ selenium derivative data set collected at a wavelength of
0.9793A ˚. Heavy atoms were identiﬁed with SHELXD (Sheldrick,
2008). The phases were calculated with SHARP and solvent
modiﬁed (Vonrhein et al, 2007). The resultant experimental map
was of excellent quality and allowed automatically building most of
the model in PHENIX (Adams et al, 2010). The model was further
manually adjusted in Coot (Emsley and Cowtan, 2004) and reﬁned
in Refmac (CCP4, 1994; Murshudov et al, 1999). The current model
of the SSD includes residues 164–345, 363–471 and 483–503 and 330
water molecules. The RAMPAGE analysis showed that 98.4% of the
residues are in favourable region, 1.3% are in allowed region and
0.3% are in outlier region (Lovell et al, 2003). A single residue
(Tyr379) falls in the outlier region of Pre-proline and displays well-
deﬁned election density.
The crystal of the Shq1–Cbf5–Nop10–Gar1 complex belongs to
space group P43212 and contains one tetramer per asymmetric unit.
The structure was solved by molecular replacement in Phaser
(McCoy et al, 2007), using the CNG complex structure and the SSD
structure as search models (Li et al, 2011). The structure was reﬁned
in Refmac to 3.06A ˚ and includes Shq1 (residues 164–347, 361–476
and 480–506), Cbf5 (18–156 and 161–378), Nop10 (1–48) and Gar1
(33–124). The structural ﬁgures were created in PyMOL (DeLano,
2002).
Pull-down assay
The Cbf5 complexes of various compositions were co-expressed and
co-puriﬁed, and Naf1 (107–280) was puriﬁed alone, as described
previously (Li et al, 2011). Naf1 (240pmol) was assembled with
120pmol Cbf5 complexes. Among these proteins, only Cbf5 had a
His tag, while Nop10 lacked a His tag, and the His tags of Gar1, Naf1
and Nhp2 were cleaved during puriﬁcation. Each of the Cbf5
complexes (120pmol) was mixed with a 4-fold molar excess of Shq1
Figure 5 The Shq1–Cbf5 interaction is important for yeast growth.
(A) Yeast growth assay of SHQ1 mutants. An shq1D haploid strain
complemented by wild-type SHQ1 on a URA3 plasmid was trans-
formed with an empty LEU2 plasmid (vector), or LEU2 plasmids
encoding wild-type SHQ1 gene (WT), SHQ1 residues 100–507
(DCS), residues 1–100 (DSSD1), residues 1–146 (DSSD2) or SHQ1
with point mutations W326D or R383E. The transformants were
grown on synthetic complete (SC) medium with 5FOA to counter-
select for the wild-type SHQ1 URA3 plasmid and on Ura- and Leu-
deﬁcient SC media (SC-Ura-Leu) at 301C. (B) Strains with HA-tagged
SHQ1 or its W326D and R383E mutants were generated as in (A)
and recovered from 5FOA plates and further grown in YPD plates at
20, 30 and 371C for indicated time. (C) The HA-tagged SHQ1 strains
were grown at indicated temperatures and analysed for protein level
by immunoblotting with anti-HA and anti-GAPDH (loading control)
antibodies.
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The EMBO Journal &2011 European Molecular Biology Organization 8Figure 6 DC mutations and Shq1 interaction. (A) Sequence alignment around the Cbf5 PUA domain. The aligned Cbf5 sequences are from S.
cerevisiae (Sc), A. thaliana (At), C. elegans (Ce), D. melanogaster (Dm), H. sapiens (Hs) and P. furiosus (Pf). Residues that are conserved in 100
and 80% of the ﬁve eukaryotic sequences are shaded by black and grey, respectively. Pf residues that match the conserved eukaryotic residues
are shaded. The observed secondary structure elements are indicated with the NTE and CTE coloured in magenta. DC mutations are labelled
and denoted by orange dots below the human dyskerin sequence (X for deletion). Yeast Cbf5 residues with solvent accessible surface buried by
at least 30 and 10A ˚ 2 due to Shq1 association are marked by blue solid and open circles, respectively. Pf Cbf5 residues buried by H/ACA RNA are
marked by red circles in a similar manner. (B) DC mutations mapped to the PUA domain and the C-terminal extension of the yeast Cbf5–Shq1
structure (cross-eye stereo-view). The DC mutation sites are indicated by orange spheres for Ca atoms and sticks, and labelled with the residue
number of yeast Cbf5. For the purposes of illustration, residues 5–11 not observed in the Shq1 complex structure are modelled as in the CNG
structure. (C) Interaction between Shq1 and yeast Cbf5 with DC mutations. The Cbf5 DC mutant complexes co-puriﬁed with either Nop10 (CN)
or Nop10 and Gar1 (CNG) were incubated with a 4-fold excess of Shq1 and pulled down with Ni beads. The input panel contained 5% of the
material used for the pull-down. Only the portion of gel containing Cbf5 and Shq1 is shown. D354 and DN15 contains Cbf5 residues 1–354 and
16–394, respectively.
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50mM sodium phosphate (pH 7.6) and 0.4M KCl. For Cbf5 with DC
mutations (Figure 6C), the binding buffer contained 50mM sodium
phosphate (pH 7.6), 0.4M NaCl and 5% glycerol. The binding
reactions were nutated gently for 2h at 41C. The Ni beads were
collected by centrifugation and washed once with 1ml 40mM
imidazole in binding buffer. Bound proteins were eluted with 20ml
500mM imidazole in binding buffer. For analysis by SDS–PAGE,
10 ml of the eluate was mixed with 10ml2  SDS-loading buffer.
ITC
ITC titrations were performed at 251C using an ITC-200 micro-
calorimeter (MicroCal Inc.). All proteins were exchanged into
50mM sodium phosphate (pH 7.6) and 0.4M KCl buffer using a
Superdex 200 16/60 column and were supplemented with 0.01%
NP-40 prior to the ITC experiment. Full-length Shq1 or its mutants
(50 or 100mM) were titrated into the Cbf5 complex (5 or 10mM) in a
200-ml sample cell by a 40-ml microsyringe as follows: 0.4ml for the
ﬁrst injection and 2ml for the next 19 injections with an interval of
150s. The integrated heat data were analysed using the one-set-of-
sites model in MicroCal Origin according to the manufacturer’s
instructions. The ﬁrst data point was not used in the analysis. The
binding parameters DH (reaction enthalpy change in cal mol
 1), K
(binding constant in M
 1) and n (number of bound Shq1 molecules
per Cbf5 complex) were ﬂoating during the ﬁt. The binding free
energy DG and reaction entropy DS were calculated using the
relationships DG¼ RTlnK (R¼1.9872 cal mol
 1 K
 1, T¼298 K)
and DG¼DH TDS. The dissociation constant Kd was calculated as
1/K. The derived thermodynamic parameters are listed in Supple-
mentary Table S1.
Yeast plasmids and strains
The wild-type SHQ1 gene, including 225bp sequences upstream of
the start codon and 300bp sequences downstream of the stop
codon, was ampliﬁed by PCR from yeast genomic DNA and cloned
into plasmid pRS416 with a URA3 marker to yield pRS416-SHQ1 and
into pRS415 with a LEU2 marker to yield pRS415-SHQ1 (Brachmann
et al, 1998). Single point mutations (W326D or R383E) and domain
deletions (DCS, DSSD1 or DSSD2) were introduced into pRS415-
SHQ1 with the QuikChange method. For domain deletions, the
whole DNA region encoding the domain of interest was removed
from the plasmid. The HA tag was inserted to the C-terminus of
SHQ1 gene by QuikChange.
The heterozygous Shq1 deletion diploid strain BY4743 SHQ1/
shq1D::kanMX4 (MAT a/a his3D1/his3D1, leu2D0/leu2D0, lys2D0/
LYS2, MET15/met15D0, ura3D0/ura3D0, SHQ1/shq1D::kanMX4)
was purchased from Euroscarf and was maintained in YPD medium
complemented with 2% glucose and 0.003% adenine. The strain
was transformed with pRS416-SHQ1, and the transformants were
sporulated and dissected. The spores were germinated into colonies
on YPD plates. Each clone was duplicated on Ura-deﬁcient synthetic
complete (SC) medium supplemented with antibiotic G418 to select
the shq1D haploid clone with URA3 pRS416-SHQ1. The surviving
clones were further examined for the absence of genomic SHQ1
copy by PCR. Growth and handling of yeast were performed by
standard techniques. Yeast cells were transformed using the
PEG/lithium acetate method. The constructed plasmids and yeast
strains and used oligonucleotides are listed in Supplementary
Tables S2–S4, respectively.
Growth assay
The shq1D haploid strain with URA3 pRS416-SHQ1 was trans-
formed with LEU2 pRS415-SHQ1 containing either wild-type or
mutant SHQ1. The transformants were grown in 2ml Ura- and Leu-
deﬁcient SC medium for 16h at 301C and adjusted to an OD600 of
0.5. The culture was serially diluted by 4-fold in 96-well plates and
spotted with a 48-pin replicator onto SC plates with 5-ﬂuoroorotic
acid (5FOA) to counter select the URA3 pRS416-SHQ1 plasmid or
without 5FOA. The plates were incubated for 3 days at 301C. The
stains with HA-tagged SHQ1 and its W326D and R383E mutant were
recovered from SC/5FOA plates, cultured in liquid YPD medium and
spotted onto YPD plates for 2–4 days at 20, 30 and 371C.
Immunoblot
For analysis of protein stability, the SHQ1–HA strains were grown in
YPD medium at 20, 30 and 371C to about 1.5 OD at 600nm. Cells of
4 OD were collected and resuspended in 150ml lysis buffer
containing 40mM Tris–Cl (pH 6.8), 5% w/v SDS, 8M urea,
0.1mM EDTA, 0.4mgml
 1 bromophenol blue and 1mM PMSF.
The sample was mixed with 80ml glass beads (0.5mm in diameter,
Biospec) and lysed with four times of 30-s vortex. The clariﬁed
supernatant (10ml) was resolved in a 4–12% gradient SDS–PAGE gel
and immunoblotted with anti-HA (Santa Cruz Biotechnology) and
anti-GAPDH antibodies.
Accession codes
The atomic coordinates and structure factors have been deposited
in the Protein Data Bank under accession number 3UAH for the
Shq1-speciﬁc domain and 3UAI for the Shq1–Cbf5–Nop10–Gar1
complex structure.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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